×

Juno, Celgene's $1B cancer-fighting deal: CEO

7:15 AM ET Tue, 30 June 2015

Hans Bishop, Juno Therapeutics CEO, discusses the company's strategic collaboration with Celgene to develop advance immunotherapies for patients with cancer and autoimmune diseases.